Trial intelligence / Profile preview

High Dose Statin and Niacin in Carotid Endarterectomy

NCT00804843Phase 2Completed

Sponsor
Merck & Co.
Start
Apr 2009
Primary completion
Oct 2010
Modality
Small Molecules
01

Overview

A Phase 2 trial of niacin in carotid atheroma (CAS), sponsored by Merck & Co.. Started Apr 2009; status: completed.

02

Drugs

niacin
03

Conditions

carotid atheroma (CAS)

Beyond the preview

Go deeper on NCT00804843.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00804843.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call